Boston Scientific (BSX) Current Assets (2009 - 2026)

Boston Scientific has disclosed Current Assets across 18 years of filings, most recently posting $8.0 billion for Q2 2026.

• In Q2 2026, Current Assets rose 11.95% year-over-year to $8.0 billion; the TTM figure through Jun 2026 stood at $8.0 billion (up 11.95% YoY), while the FY2025 annual figure was $8.8 billion, up 27.08% from the prior year.
• Current Assets came in at $8.0 billion for Q2 2026 at Boston Scientific, down from $8.7 billion in the prior quarter.
• In the past five years, Current Assets ranged from a high of $9.0 billion in Q2 2024 to a low of $5.1 billion in Q1 2022.
• Average Current Assets over 5 years is $7.0 billion, with a median of $7.0 billion recorded in 2024.
• Year-over-year, Current Assets slipped 24.79% in 2022 and surged 52.75% in 2024.
• Over 5 years, Current Assets stood at $5.8 billion in 2022, then increased by 13.09% to $6.5 billion in 2023, then climbed by 6.23% to $6.9 billion in 2024, then climbed by 27.08% to $8.8 billion in 2025, then decreased by 9.35% to $8.0 billion in 2026.
• Per Business Quant data, the three most recent Current Assets figures were $8.0 billion in Q2 2026, $8.7 billion in Q1 2026, and $8.8 billion in Q4 2025.